KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Liabilities and Shareholders Equity (2016 - 2026)

Gilead Sciences filings provide 17 years of Liabilities and Shareholders Equity readings, the most recent being $59.0 billion for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity changed 0.05% to $59.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $229.7 billion, a 2.83% increase, with the full-year FY2025 number at $59.0 billion, changed 0.05% from a year prior.
  • Liabilities and Shareholders Equity hit $59.0 billion in Q4 2025 for Gilead Sciences, up from $58.5 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $68.0 billion in Q2 2021 to a low of $53.6 billion in Q2 2024.
  • Median Liabilities and Shareholders Equity over the past 5 years was $62.2 billion (2023), compared with a mean of $61.2 billion.
  • Biggest five-year swings in Liabilities and Shareholders Equity: rose 21.54% in 2021 and later dropped 14.05% in 2024.
  • Gilead Sciences' Liabilities and Shareholders Equity stood at $68.0 billion in 2021, then dropped by 7.04% to $63.2 billion in 2022, then decreased by 1.66% to $62.1 billion in 2023, then fell by 5.04% to $59.0 billion in 2024, then increased by 0.05% to $59.0 billion in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $59.0 billion (Q4 2025), $58.5 billion (Q3 2025), and $55.7 billion (Q2 2025) per Business Quant data.